Johnson & Johnson news

   Watch this stock
Showing stories 11 - 20 of about 118   

Articles published

JNJ 106.19 +0.31 (0.29%)
price chart
Johnson & Johnson Should Ignore Those Breakup Calls
Still, there are plenty of investors calling for Johnson & Johnson to break itself up into smaller pieces, even though the company is posting 9% year-over-year revenue growth.
Johnson & Johnson: The One Stock You Should Ever Own? (JNJ)  Seeking Alpha (registration)
Short Interest in Johnson & Johnson Decreases By 13.2% (JNJ)  Mideast Time
Related articles »  
Johnson & Johnson Seems Expensive Relative To Historical Valuation Metrics ...
However, recall that Johnson & Johnson's expected future earnings growth rate is higher than it has been in the previous several years, so that factor helps explain this elevated valuation.
Related articles »  
Johnson & Johnson Accused Of Concealing Hip Implant Defect
Mark Lanier, the lawyer leading the Pinnacle hip implant lawsuit against Johnson & Johnson, has accused the company of being aware of the defects since 2001.
Interesting January 2015 Stock Options for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson JNJ +0.13% (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract ...
Related articles »  
3 Reasons Johnson & Johnson Stock Could Rise
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ ) might be a $280-plus billion dollar company, but it's certainly not growing like one as evidenced by the company's robust growth reported in the second quarter.
Related articles »  
3 Reasons Johnson & Johnson's Stock Could Fall
Bet against healthcare conglomerate Johnson & Johnson (NYSE: JNJ ) and you're liable to get hurt. Sure, it sounds like a line right out of The Sopranos, but it's the truth if you've dared to short-sell Johnson & Johnson's stock over the past four ...
Related articles »  
Johnson & Johnson Becomes #14 Most Shorted Dow Stock, Replacing Procter ...
The most recent short interest data has been released by the NASDAQ for the 08/15/2014 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by ...
Related articles »  
Bristol-Myers Squibb's Daklinza Threatens Johnson & Johnson More Than ...
In order to treat those patients, doctors have increasingly embraced prescribing Johnson & Johnson's Olysio, another oral hepatitis C drug that won regulatory approval in the fourth quarter, alongside Sovaldi.
Related articles »  
Will This Ratings Initiation Help Johnson & Johnson (JNJ) Stock Today?
The firm said it initiated coverage on the company, which is engaged in research and development, as well as the sale of a variety of health care products, as it believes Johnson & Johnson is an industry leader and can break into emerging markets. BMO ...
Johnson & Johnson Receives New Coverage from Analysts at BMO Capital ...  Watch List News (press release)
Johnson & Johnson Now Covered by Analysts at BMO Capital Markets (JNJ)  sleekmoney
Related articles »  
Johnson & Johnson In Trouble Again
These content links are provided by Both and the web site upon which the links are displayed may receive compensation when readers click on these links.
J&J's Pinnacle Hips Face First Trial on Poisoned Patients  Bloomberg
Related articles »